bufalin has been researched along with Experimental Mammary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dong, Z; Du, S; Hu, H; Lu, Y; Luo, J; Mo, Y; Qi, Q; Wang, Y; Yu, X | 1 |
Liu, Y; Qu, X; Song, N; Teng, Y; Xu, C; Xu, L; Yan, S; Zhang, L; Zhu, Z | 1 |
2 other study(ies) available for bufalin and Experimental Mammary Neoplasms
Article | Year |
---|---|
Albumin coated trimethyl chitosan-based targeting delivery platform for photothermal/chemo-synergistic cancer therapy.
Topics: Animals; Bufanolides; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Indoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Tumor Microenvironment | 2020 |
Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-cbl; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA Interference; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |